**Sekhmet Pharmaventures Expands API and Formulation Offerings**
Sekhmet Pharmaventures, a leading API and formulation provider, showcased its extensive portfolio at CPHI & PMEC India 2024.
The company, boasting over 150 APIs and several formulations, provides CDMO services to global pharma and biotech companies. With FDA, PMDA, and European GMP-approved assets, Sekhmet is expanding its reach into both regulated and less regulated markets.
“We’re committed to delivering innovative solutions and services for the growing healthcare industry,” said the company’s CEO.Generated by Gemini
